| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8668302 | Journal of Clinical Lipidology | 2018 | 21 Pages |
Abstract
TTB is variable among trials of cholesterol-lowering drugs, being shorter with statin compared to nonstatin drugs. TTB is shorter with atorvastatin than with other statins. For trials of new cholesterol-lowering drugs, outcome curves that do not separate for up to 30Â months do not preclude eventual benefit.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Philip J. MD, PhD, David D. MD,